Nautisol (Prochlorperazine Maleate)

Prochlorperazine, the active ingredient in Nautisol, is a phenothiazine presented as an oral formulation for oral use. It is employed to control nausea, vomiting, vertigo, migraine‑associated nausea and psychotic disorders in adult patients. GNH USA supplies Nautisol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Prochlorperazine acts as an antiemetic and antipsychotic across several clinical pathways. - Nausea and vomiting: reduces acute and chemotherapy‑induced nausea and vomiting. - Vertigo and motion sickness: alleviates dizziness and associated nausea. - Migraine‑associated nausea: helps control nausea accompanying migraine attacks. - Schizophrenia and other psychotic disorders: mitigates psychotic symptoms such as hallucinations and delusions.

Prochlorperazine may cause a range of adverse reactions.

Common Side Effects: - Drowsiness or sedation - Dry mouth - Constipation - Blurred vision - Orthostatic hypotension - Weight gain

Serious or Rare Side Effects: - Extrapyramidal symptoms (e.g., dystonia, akathisia) - Tardive dyskinesia with long‑term use - Neuroleptic malignant syndrome - Severe hypotension or cardiac arrhythmia - Hematologic abnormalities such as leukopenia

Use of Prochlorperazine requires careful clinical monitoring. - Extrapyramidal monitoring: watch for muscle rigidity, tremor, or abnormal movements. - Cardiovascular assessment: evaluate blood pressure and heart rhythm, especially in patients with cardiac disease. - Elderly caution: dose may need adjustment due to increased sensitivity to sedation and hypotension. - Hypersensitivity: discontinue if rash, itching, or swelling occurs. - CNS depressants: avoid concurrent use with alcohol or other sedatives without supervision. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Prochlorperazine can interact with several drug classes.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension or serotonin syndrome. - Other dopamine antagonists: additive extrapyramidal effects. - QT‑prolonging agents: increased risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs: may exacerbate dry mouth and constipation. - CNS depressants (e.g., benzodiazepines, opioids): enhanced sedation and respiratory depression. - Antihypertensives: additive hypotensive effect.